LACK OF CORRELATION BETWEEN PERIPHERAL-BLOOD LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-FUNCTION AND CLINICAL-RESPONSE IN PATIENTS WITH ADVANCED MALIGNANT-MELANOMA RECEIVING RECOMBINANT INTERLEUKIN-2

被引：50

作者：

GHOSH, AK ^{[1
]}

DAZZI, H ^{[1
]}

THATCHER, N ^{[1
]}

MOORE, M ^{[1
]}

机构：

[1] CHRISTIE HOSP & HOLT RADIUM INST,DEPT MED ONCOL,MANCHESTER M20 9BX,LANCS,ENGLAND

来源：

INTERNATIONAL JOURNAL OF CANCER | 1989年 / 43卷 / 03期

关键词：

D O I：

10.1002/ijc.2910430311

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：410 / 414

页数：5

共 33 条

[21]

LOTZE MT, 1985, J IMMUNOL, V135, P2865

[22] RECOMBINANT INTERLEUKIN-2 DIRECTLY AUGMENTS THE CYTOTOXICITY OF HUMAN-MONOCYTES [J].

MALKOVSKY, M ;

LOVELAND, B ;

NORTH, M ;

ASHERSON, GL ;

GAO, L ;

WARD, P ;

FIERS, W .

NATURE, 1987, 325 (6101) :262-265

[23] SUCCESSFUL IMMUNOTHERAPY OF NATURAL KILLER-RESISTANT ESTABLISHED PULMONARY MELANOMA METASTASES BY THE INTRAVENOUS ADOPTIVE TRANSFER OF SYNGENEIC LYMPHOCYTES ACTIVATED INVITRO BY INTERLEUKIN-2 [J].

MAZUMDER, A ;

ROSENBERG, SA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (02) :495-507

[24]

MCMANNIS JD, 1988, J IMMUNOL, V140, P1335

[25]

MONAGHEGHPOUR N, 1984, J IMMUNOL, V133, P133

[26] ADOPTIVE IMMUNOTHERAPY OF ESTABLISHED PULMONARY METASTASES WITH LAK CELLS AND RECOMBINANT INTERLEUKIN-2 [J].

MULE, JJ ;

SHU, SY ;

SCHWARZ, SL ;

ROSENBERG, SA .

SCIENCE, 1984, 225 (4669) :1487-1489

[27]

NII A, 1988, INT J CANCER, V41, P33

[28]

OWENSCHAUB LB, 1988, CANCER RES, V48, P788

[29] SPONTANEOUS HUMAN LYMPHOCYTE-MEDIATED CYTOTOXICITY AGAINST TUMOR TARGET-CELLS .1. EFFECT OF MALIGNANT DISEASE [J].

PROSS, HF ;

BAINES, MG .

INTERNATIONAL JOURNAL OF CANCER, 1976, 18 (05) :593-604

[30] IMMUNOTHERAPY OF CANCER USING INTERLEUKIN-2 - CURRENT STATUS AND FUTURE-PROSPECTS [J].

ROSENBERG, SA .

IMMUNOLOGY TODAY, 1988, 9 (02) :58-62

← 1 2 3 4 →